These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20616602)

  • 1. Real practice of hepatocellular carcinoma in Japan: conclusions of the Japan Society of Hepatology 2009 Kobe Congress.
    Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():180-8. PubMed ID: 20616602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and treatment algorithm of the Japanese society of hepatology: a consensus-based practice guideline.
    Izumi N
    Oncology; 2010 Jul; 78 Suppl 1():78-86. PubMed ID: 20616588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
    Kudo M; Okanoue T;
    Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients.
    Yen YH; Changchien CS; Wang JH; Kee KM; Hung CH; Hu TH; Lee CM; Lin CY; Wang CC; Chen TY; Huang YJ; Lu SN
    Dig Liver Dis; 2009 Jun; 41(6):431-41. PubMed ID: 19185555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
    Kudo M; Chung H; Osaki Y
    J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
    Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
    J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M
    Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the clinical practice guidelines for hepatocellular carcinoma in Japan and Western countries].
    Ikai I
    Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):343-8. PubMed ID: 19068716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
    Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M;
    Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The diagnostic approach to hepatocellular carcinoma].
    Schacherer D; Schoelmerich J; Zuber-Jerger I
    Z Gastroenterol; 2007 Oct; 45(10):1067-74. PubMed ID: 17924305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
    Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
    Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostics and treatment of hepatocellular carcinoma. Recommendations of the Portal Hypertension Working Group of the Czech Hepatology Society and the J.E. Purkinje Czech Medical Society ].
    Brůha R; Drastich P; Hůlek P; Lata J; Petrtýl J; Procházka J; Spicák J; Vanásek T; Volfová M; Zdenek P;
    Vnitr Lek; 2005 Dec; 51(12):1406-8. PubMed ID: 16430109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy.
    Nanashima A; Sumida Y; Morino S; Yamaguchi H; Tanaka K; Shibasaki S; Ide N; Sawai T; Yasutake T; Nakagoe T; Nagayasu T
    Eur J Surg Oncol; 2004 Sep; 30(7):765-70. PubMed ID: 15296991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of treatment methods for hepatocellular carcinoma--based on JIS score].
    Kudo M; Chung H; Osaki Y; Kasugai H; Oka H; Seki T
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2100-4. PubMed ID: 15628751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the management of hepatocellular carcinoma: consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of Japan.
    Kudo M; Matsui O; Sakamoto M; Kitao A; Kim T; Ariizumi S; Ichikawa T; Kobayashi S; Imai Y; Izumi N; Fujinaga Y; Arii S
    Oncology; 2013; 84 Suppl 1():21-7. PubMed ID: 23428854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI; Lin HC; Huang YH; Wu JC; Chiang JH; Lee PC; Lee SD
    Cancer; 2006 Jul; 107(1):141-8. PubMed ID: 16708358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score.
    Chung H; Kudo M; Takahashi S; Hagiwara S; Sakaguchi Y; Inoue T; Minami Y; Ueshima K; Fukunaga T; Matsunaga T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):445-52. PubMed ID: 17683486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern diagnosis and management of hepatocellular carcinoma.
    Marrero JA; Welling T
    Clin Liver Dis; 2009 May; 13(2):233-47. PubMed ID: 19442916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and multimodal therapy for hepatocellular carcinoma].
    Kolligs FT; Hoffmann RT; op den Winkel M; Bruns CJ; Herrmann K; Jakobs TF; Lamerz R; Trumm C; Zech CJ; Wilkowski R; Graeb C
    Z Gastroenterol; 2010 Feb; 48(2):274-88. PubMed ID: 20119895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Practice guidelines for management of hepatocellular carcinoma 2009].
    Korean Liver Cancer Study Group and National Cancer Center, Korea
    Korean J Hepatol; 2009 Sep; 15(3):391-423. PubMed ID: 19783891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.